While Sanofi’s immunology megablockbuster Dupixent predictably dominated the company’s sales charts in 2024, a new golden child could be emerging in the form of Beyfortus. During its first ...

In response to discussions about affirmative consent laws, and the need to demonstrate consent has been sought and given, ...

The beyfortus market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX ...

The order from Trump — an order we all suspected would come down — leaves in question whether the consent decree between the city of Louisville and the Department of Justice sitting on a ...

In Utah, patients who consent to "hormonal transgender treatment" or surgery on "sex characteristics" while they are minors are able to revoke their informed consent if they later regret receiving the ...

Wells Fargo WFC-1.95%decrease; red down pointing triangle said Tuesday that its 2022 consent order with the Consumer Financial Protection Bureau relating to auto lending, consumer deposit accounts ...

Lantus sales rose 63.4% to €439.0 million. SNY & AZN’s Beyfortus Drives Vaccine Sales Total vaccine sales increased 10.8% to €2.2 billion, driven by Beyfortus sales in Europe. Sales of flu ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins Some states have laws and ethical rules regarding solicitation and ...

NEW YORK, Feb 11 (Reuters) - A top Wells Fargo (WFC.N), opens new tab executive said on Tuesday that the bank has five consent orders remaining to resolve issues related to its lending and sales ...

Sobi's acquired immunology drugs (Astra's Synagis and Beyfortus, Novimmune's Gamifant, Apellis' Aspaveli) and hematology drugs (Dova's platelet drug Doptelet, ADC's blood cancer drug Zynlonta ...

The panel voted 21 to zero that Beyfortus (nirsevimab) appears to be safe and effective at preventing RSV infections in newborns and infants as they face their first RSV season, setting the drug ...

The final obstacle to the routine use of Sanofi and AstraZeneca's Beyfortus to prevent respiratory syncytial virus (RSV) in the US has fallen after it was backed by Centres for Disease Control and ...